A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.

Item

http://www.wikidata.org/entity/Q42396665

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.

@en

A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.

@nl

type

Item

label

A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.

@en

A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.

@nl

prefLabel

A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.

@en

A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.

@nl

P1476

A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.

@en

P2093

Brian B Cai

http://www.w3.org/2001/XMLSchema#string

Catherine Rhéaume

http://www.w3.org/2001/XMLSchema#string

Ester Fernández-Salas

http://www.w3.org/2001/XMLSchema#string

Joanne Wang

http://www.w3.org/2001/XMLSchema#string

Joseph Francis

http://www.w3.org/2001/XMLSchema#string

K Roger Aoki

http://www.w3.org/2001/XMLSchema#string

Ron S Broide

http://www.w3.org/2001/XMLSchema#string

P2860

Development of onabotulinumtoxinA for chronic migraine

Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay

Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).

The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways.

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

How botulinum and tetanus neurotoxins block neurotransmitter release.

Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains.

A decade of site- and phosphorylation state-specific antibodies: recent advances in studies of spatiotemporal protein phosphorylation.

The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes

Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).

P304

2354-2370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/TOXINS7072354

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280091347

http://www.w3.org/2001/XMLSchema#string

P698

26114335

http://www.w3.org/2001/XMLSchema#string

P932

4516917

http://www.w3.org/2001/XMLSchema#string